TrialBlood advances2021

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.

Lale Kostakoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.